Login / Signup
Lower leukemia burden maximizes the impact of blinatumomab therapy.
Aaron C Logan
Published in:
Cancer (2023)
Keyphrases
</>
acute lymphoblastic leukemia
acute myeloid leukemia
bone marrow
risk factors
stem cells